Skip to main navigation Skip to search Skip to main content

Duvelisib, a novel oral dual inhibitor of PI3K-d,g, is clinically active in advanced hematologic malignancies

  • Ian W. Flinn
  • , Susan O’Brien
  • , Brad Kahl
  • , Manish Patel
  • , Yasuhiro Oki
  • , Francine F. Foss
  • , Pierluigi Porcu
  • , Jeffrey Jones
  • , Jan A. Burger
  • , Nitin Jain
  • , Virginia M. Kelly
  • , Kerstin Allen
  • , Mark Douglas
  • , Jennifer Sweeney
  • , Patrick Kelly
  • , Steven Horwitz

Research output: Contribution to journal › Article › peer-review

229   Link opens in a new tab Scopus citations

Fingerprint

Dive into the research topics of 'Duvelisib, a novel oral dual inhibitor of PI3K-d,g, is clinically active in advanced hematologic malignancies'. Together they form a unique fingerprint.
Sort by

Keyphrases

Medicine and Dentistry

Pharmacology, Toxicology and Pharmaceutical Science